Bpifrance

Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.

Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

H'ability specializes in providing immersive virtual reality (VR) therapeutic exercises that complement traditional rehabilitation methods. The company offers a wireless VR headset with customizable exercises targeting motor skills, balance, and cognitive functions. Their platform features real-time session personalization, detailed progress tracking with data analytics, and compatibility with additional rehabilitation tools. This enables healthcare professionals to deliver personalized, engaging, and efficient therapy sessions in clinical settings or at patients' homes, catering to various medical conditions.

MSInsight is a bioinformatics startup specializing in the development of diagnostic and treatment response prediction solutions for microsatellite instability (MSI) cancers. The company offers a platform that utilizes next-generation sequencing data to analyze MSI status, a crucial biomarker in oncology. By providing actionable insights on this biomarker, MSInsight enables healthcare professionals to make informed decisions about patient care, particularly concerning treatment options such as immunotherapy. The focus on diagnostic and prognostic biomarkers of treatment response enhances the ability to improve overall patient outcomes in the oncology market.

Superbranche is a biotechnology company focused on the early detection and treatment of metastases through innovative nanotechnological solutions. The company develops therapeutic and diagnostic applications aimed at improving accessibility and enabling the early identification of tumors. Utilizing proprietary technology, Superbranche's platform delivers targeted diagnostic tools and image-guided therapy nanomaterials to clinical settings, enhancing the effectiveness of cancer treatment by allowing for timely interventions. Through its advancements in nanotechnology, Superbranche seeks to transform the landscape of cancer care by prioritizing early detection and personalized treatment strategies.

Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on the clinical development of first-in-class drug candidates aimed at treating and preventing diseases affecting pets, including periodontitis, osteoarthritis, and gut motility disorders. By prioritizing the creation of effective treatments for common health issues, Vetbiolix aims to enhance the quality of life for pets and their owners.

Orakl Oncology specializes in expediting cancer drug discovery by employing advanced biology and AI-driven analysis. It maintains a unique collection of patient tumor avatars, integrating biological and clinical data, to create realistic tumor models that mimic real-life drug responses. By mining multi-modal experimental data and combining it with deep patient data, Orakl enables oncology companies to identify relevant targets and develop more effective treatments at an accelerated pace.

Biolevate is an AI-driven company focused on enhancing the healthcare sector through advanced technology. It provides innovative solutions for researchers and medical professionals by automating essential tasks such as document generation and literature monitoring. By leveraging sophisticated AI algorithms, Biolevate enables effective knowledge management that streamlines research workflows and accelerates scientific discovery. The company's tools intelligently filter extensive datasets, prioritizing relevant scientific information and offering customizable search options along with insightful data visualizations. Through this approach, Biolevate empowers clients to make informed decisions and facilitates significant advancements in medical research, ultimately aiming to improve patient care.

Doado is a health technology company that specializes in developing mobile applications for back health management. Its primary product is an e-health application designed to guide users step by step in improving their back health and preventing Musculoskeletal Disorders. The application offers personalized video programs, expert advice from physiotherapists and doctors, and AI-driven progress tracking, enabling individuals and companies to maintain an active lifestyle and reduce the risk of chronic back pain.

Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on the clinical development of first-in-class drug candidates aimed at treating and preventing diseases affecting pets, including periodontitis, osteoarthritis, and gut motility disorders. By prioritizing the creation of effective treatments for common health issues, Vetbiolix aims to enhance the quality of life for pets and their owners.

Enalees is a biotechnology company focused on developing molecular diagnostic tests specifically for pets, with a particular emphasis on leisure animals such as horses. The company has created a platform that provides DNA tests designed to detect the microbes responsible for infectious diseases. These tests enable veterinarians to quickly identify the pathogens causing an animal's illness, facilitating timely and accurate diagnosis. By supplying veterinary clinics with diagnostic test kits, Enalees aims to enhance the efficiency of infectious disease management in animals, ultimately improving animal health outcomes.

Archeon Medical specializes in the development of innovative solutions aimed at enhancing the monitoring, diagnosis, and treatment of critically ill patients during prehospital care. The company utilizes artificial intelligence to create disruptive technologies that focus on improving ventilation quality in emergency medical services. Archeon Medical's products are practical, easy to use, and intuitive, providing emergency caregivers with real-time feedback on the quality of ventilation administered to patients. Through its commitment to advancing prehospital care, Archeon Medical seeks to optimize patient outcomes in critical situations.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

Klineo is a healthcare platform focused on enhancing access to clinical trials for oncology patients. It features an intuitive and intelligent search interface that caters to both healthcare professionals and patients. The platform allows users to efficiently locate relevant clinical trials for specific conditions such as breast, skin, and lymphoma cancers, facilitating contact with trial centers and improving the overall trial search experience. By connecting patients and doctors with appropriate clinical research opportunities, Klineo aims to streamline the process of finding critical treatment options in the oncology field.

Pixacare is a developer of a medical imaging application that enhances wound care management for healthcare professionals. This secure platform automates medical photo management and centralizes critical data for monitoring wounds, making it user-friendly and accessible on both mobile and desktop devices. Designed as a Class I CE-marked digital medical device, Pixacare's application transforms any smartphone camera into a secure documentation tool, enabling home-care staff, surgeons, and dermatologists to effectively monitor and anticipate complications in chronic and post-surgery wounds. By integrating seamlessly with healthcare infrastructures, including Patient Administration Systems and Electronic Health Records, Pixacare ensures data security through hosting on a certified Health Data Hosting server, thereby optimizing the workflow of medical professionals.

Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.

Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing users' day-to-day data, including fat levels and energy metabolism dynamics, Metyos provides personalized fitness and nutrition routines. The company's aim is to help individuals understand how their bodies respond to their actions, thereby empowering them to achieve their weight goals and regain control over their health.

HawkCell is a medical research company specializing in advanced magnetic resonance imaging (MRI) solutions for veterinary clinics and preclinical research laboratories. By utilizing a non-ionizing three-dimensional (3D) imaging approach, HawkCell employs specialized MRI sensors designed to accommodate various animal morphologies. The company enhances its services with artificial intelligence algorithms, transforming traditional human MRI technology into dedicated imaging resources tailored for animal diagnostics and scientific exploration. This innovative approach provides veterinary clinics and research labs with precise and insightful tools for improving animal healthcare and advancing research initiatives.

Bioptimus is a biotechnology company focused on developing a universal artificial intelligence foundation model that integrates various scales of biology, from molecules to cells, tissues, and entire organisms. The company's innovative technology leverages generative AI to transform complex multiscale biological data into actionable insights, facilitating significant advancements in scientific research and biomedical innovation. By enabling clients to effectively harness this data, Bioptimus aims to drive breakthrough discoveries and enhance the efficiency of biotechnological processes.

Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

Huvy is a company that utilizes artificial intelligence to enhance dermatological treatment pathways and provide essential medical information in real-time. It has developed a skin cancer screening application aimed at identifying cancer risks. This application facilitates dermatological screenings, particularly benefiting populations in areas with limited access to medical services. By offering initial diagnostic orientation, Huvy's technology enables patients to receive timely care if there is a suspicion of skin cancer, thus improving early detection and treatment outcomes.

Steto Its mission is to create solutions for remote patient monitoring and digital diabetes therapies.

Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

Diamidex SAS, established in 2014 and based in Marseille, France, specializes in the development and production of rapid detection tests for legionella, a type of bacteria that can cause severe lung infections. The company offers turnkey test solutions, designed for both laboratory and field use, which provide semi-quantitative counts of microorganisms in water samples and industrial goods. Diamidex's products aim to enhance the accuracy and speed of microbial contamination detection, facilitating more efficient screening and data collection in research and testing environments.

Nonna Lab is a company dedicated to producing anti-hangover drinks designed to alleviate the discomfort associated with hangovers. Its products incorporate vegan, low-sugar, and all-natural ingredients that are formulated to be quickly absorbed by the body. By focusing on effective relief, Nonna Lab enables individuals to enjoy social events without the concern of experiencing significant aftereffects. The company aims to provide a solution that allows for a more enjoyable experience while promoting well-being.

Resolve Stroke, headquartered in Paris, is a HealthTech company dedicated to revolutionizing medical imaging. It specializes in enhancing ultrasound technology to extract more detailed information, enabling advanced diagnostics, particularly in neurology. The company's innovative software engines improve ultrasound contrast, resolution, and penetration depth, allowing for the visualization of micro-vessels through the human skull in 3D. With a global focus, Resolve Stroke aims to accelerate treatments for over 1 billion people affected by brain diseases. To date, it has secured €3 million in pre-seed funding to pioneer software-based ultrasound innovation.

BioMAdvanced Diagnostics is a company focused on developing molecular diagnostic and biomarker tests that enhance patient care through individualized treatment strategies. Their innovative tests are designed to integrate seamlessly into existing diagnostic and treatment protocols, ensuring ease of use for healthcare personnel. By providing predictive scores and identifying biomarkers, BioMAdvanced Diagnostics enables clinicians to assess the immune response of patients and evaluate the risk of transplant rejection. This capability allows for improved anticipation and adaptation of treatment plans, ultimately aiming to enhance patient outcomes significantly.

GenSensor is a biotechnology company that specializes in developing and implementing a genomic-based, in-line bioproduction monitoring system. This system combines a robotic device with advanced analytics software to monitor, characterize, and optimize the production of advanced therapy medicinal products (ATMPs) and vaccines. By providing real-time insights into the bioproduction process, GenSensor helps healthcare companies maximize the use of innovative drugs, improve production efficiency, and ultimately reduce manufacturing costs, thereby benefiting patients.

Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Numa Health is a medical bioinformatics health technology company that focuses on empowering individuals to optimize their health capital and well-being. It has developed a digital health platform that offers tools designed to enhance users' commitment to their health. This platform facilitates the reinterpretation of blood test results, providing insights into bodily functions and overall health. By enabling users to measure, understand, and take actionable steps regarding their health, Numa Health aims to support individuals in their journey towards better health management.

CorWave is a company focused on developing innovative implanted cardiac support devices aimed at improving the quality of life for patients suffering from heart failure. Its flagship product, the CorWave LVAD, employs a unique undulating disc wave pumping mechanism, which replaces traditional high-speed impellers used in current continuous flow rotary pumps. This design significantly reduces trauma to blood, thereby minimizing complications such as clotting and bleeding. The CorWave pump generates a pulsatile flow that closely resembles the natural heartbeat, addressing a key limitation of existing LVADs that provide only continuous flow. Additionally, the device's low power consumption and compact size facilitate its potential for complete implantation, enhanced by a wireless energy transfer system. Through these advancements, CorWave aims to alleviate the burdens associated with heart failure and invasive surgical procedures.

Maddie is a healthcare technology company that offers software solutions designed for physiotherapists and other health professionals. Its platform enables effective practice management through features such as dematerialized diaries, online appointment bookings, and customizable websites. These tools assist healthcare providers in organizing waiting lists, optimizing schedules, and managing incoming requests efficiently. By streamlining administrative tasks, Maddie aims to enhance the operational capabilities of health professionals, allowing them to focus more on patient care.

MOTEN Technologies specializes in developing advanced muscle sensor technology and analysis platforms aimed at preventing musculoskeletal disorders (MSDs). The company offers solutions that measure muscular effort and monitor body motion, providing valuable insights into muscular fatigue. By assisting decision-makers in optimizing workstations and tasks assigned to operators, MOTEN Technologies helps organizations reduce the risks associated with MSDs and enhance employee health and safety. Additionally, the company provides data processing and analysis software services, along with personalized support to ensure effective implementation of its technologies.

Divie is a retail company that sells wellness products through its website. Their product categories such as drinks, oils, botanicals, herbal teas, isolates, plant oils, and infusions.

BioMAdvanced Diagnostics is a company focused on developing molecular diagnostic and biomarker tests that enhance patient care through individualized treatment strategies. Their innovative tests are designed to integrate seamlessly into existing diagnostic and treatment protocols, ensuring ease of use for healthcare personnel. By providing predictive scores and identifying biomarkers, BioMAdvanced Diagnostics enables clinicians to assess the immune response of patients and evaluate the risk of transplant rejection. This capability allows for improved anticipation and adaptation of treatment plans, ultimately aiming to enhance patient outcomes significantly.

Incepto Medical SAS, established in 2018 and headquartered in Paris, France, specializes in developing and distributing artificial intelligence (AI) applications for medical imaging. Its portfolio includes software solutions like Qure.ai qER and qXR for head CT and thorax abnormality detection, Aidence Veye Chest for pulmonary nodule tracking, Icometric Icobrain for neurological disorder monitoring, and ScreenPoint Transpara for breast cancer detection. Additionally, Incepto operates Collective Minds Radiology, an online platform fostering case support, opinion sharing, and learning among healthcare professionals. The company aims to empower medical practitioners by providing AI-driven tools that address the challenges posed by increasing patient volumes and image data.

Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Nurea is a company that focuses on providing decision-making support solutions for healthcare professionals, particularly vascular surgeons. It specializes in the development of medical imaging software aimed at the diagnosis of vascular diseases. Nurea's platform automates the analysis of medical images, offering accurate quantitative assessments and decision indicators that assist in managing patient groups during both pre and post-operative monitoring. By streamlining the workflow associated with full-body scan analysis, Nurea enables surgeons to simplify their decision-making processes and improve patient outcomes in the context of cardiovascular diseases.

Intradys is a developer of advanced medical software technologies focused on interventional neuroradiology. The company specializes in creating algorithms that integrate machine learning and mixed reality, providing practitioners with tailored strategies based on various factors, including patient age, medical history, and the suitability of devices for specific pathological conditions. By utilizing images captured before or during procedures, Intradys empowers neuroradiologists to make informed decisions in real-time within the operating room, thereby enhancing the effectiveness and accuracy of surgical interventions.

Implicity is a developer of a remote monitoring platform that focuses on patients with connected cardiac implants, such as pacemakers and defibrillators. The company's software-as-a-service (SaaS) platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on the medical context of each individual. This technology allows cardiologists and healthcare professionals to automate the monitoring process, facilitating efficient oversight of patient health and enhancing the quality of care. By consolidating patient information and alerts on a single platform, Implicity aims to improve the management of cardiac conditions and support hospital teams in delivering optimal patient outcomes.

Istya is a company founded in 2021 and headquartered in Ile-de-France, France, specializing in indoor air quality solutions. The company develops advanced air quality sensors that monitor and predict air conditions, measuring fine particles and providing real-time data. Istya’s technology is designed to help businesses optimize their ventilation systems, reducing energy costs while minimizing the risk of airborne virus transmission. By offering customized sensors and predictive analysis, Istya enables organizations to create healthier indoor environments, ensuring access to clean and sustainable air.

Archeon Medical specializes in the development of innovative solutions aimed at enhancing the monitoring, diagnosis, and treatment of critically ill patients during prehospital care. The company utilizes artificial intelligence to create disruptive technologies that focus on improving ventilation quality in emergency medical services. Archeon Medical's products are practical, easy to use, and intuitive, providing emergency caregivers with real-time feedback on the quality of ventilation administered to patients. Through its commitment to advancing prehospital care, Archeon Medical seeks to optimize patient outcomes in critical situations.

Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.

NaoX Technologies is a company focused on the prevention of neurological disorders through innovative technology. It develops wireless headphones equipped with integrated sensors that passively monitor brain vibrations to record electroencephalogram data in real time. This data is then aggregated and presented on a software dashboard for healthcare providers, facilitating better diagnosis and treatment for patients. The company's mission is to democratize access to neurological disorder prevention, aiming to enhance patient outcomes and support recovery from mental illness.

Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

Pherecydes Pharma SA is a biotechnology company based in Romainville, France, that specializes in the research and development of lytic bacteriophages for therapeutic and diagnostic purposes, particularly in the context of antibiotic resistance. Established in 2006, the company is dedicated to creating personalized phage therapies aimed at treating bacterial infections. It has developed several banks of bacteriophages, including those targeting Escherichia coli, and has initiated multicenter clinical trials across Europe to assess the efficacy of phage therapy in treating infected burn wounds. By harnessing the natural ability of bacteriophages to infect and eliminate bacteria without affecting human cells, Pherecydes Pharma aims to provide innovative solutions for combating a wide range of bacterial threats, including multi-resistant and emergent strains.

Hypno VR SAS is a company that specializes in developing and operating virtual reality-based medical hypnosis solutions aimed at managing pain and stress. Founded in 2016 and headquartered in Strasbourg, France, Hypno VR creates applications designed to facilitate medical hypnosis during procedures, thereby reducing anxiety and discomfort for patients. The company's technology is particularly beneficial in various medical fields, including pediatric surgery, gastroenterology, gynecology, and dental surgery. In addition to its software solutions, Hypno VR also develops virtual reality hardware tailored for medical applications, catering to health professionals and institutions seeking innovative ways to enhance patient care.

Core for Tech is a deep technology company dedicated to enhancing road safety by measuring and predicting driver drowsiness through heart rate variability analysis. By utilizing native sensors or retrofit technology in vehicles, the company transforms physiological data into actionable insights regarding a driver's fatigue levels. This innovative approach allows for the early detection of drowsiness, enabling timely interventions to prevent accidents caused by sleepiness. With a mission centered on safety, Core for Tech aims to provide drivers with the information they need to make informed decisions about their alertness while driving.

Echoliv is a medical technology company specializing in artificial intelligence solutions for abdominal ultrasound. They develop software, namely Ultraliv, designed to aid radiologists and hepatologists in early-stage detection of hepatocellular carcinoma (HCC), the most common type of liver cancer. The algorithm enhances diagnostic capabilities by identifying nodules that may have been overlooked by practitioners during ultrasound screening.

Provepharm Life Solutions SA is a life sciences company based in Marseille, France, specializing in contract research and development services for small molecules and therapeutic peptides. Founded in 1998, the company focuses on the development, manufacturing, and marketing of pharmaceutical products and active ingredients. A key offering is pharmacopoeial grade methylene blue, a versatile compound utilized in various human health applications, including as an antidote for methemoglobinemia, a mild urinary antiseptic, and a topical antiseptic. The company also addresses animal health needs, providing solutions for toxicosis and aquaculture. Methylene blue serves additional roles as a laboratory dye, indicator, and diagnostic aid in surgical procedures. Provepharm Life Solutions aims to lead in the life sciences sector through its innovative approach, known as Molecule Vitalization, and offers a range of research and manufacturing services to advance health solutions.

Pixyl is a company specializing in a neuroimaging cloud platform aimed at enhancing patient care for radiologists and clinicians. Its platform, Pixyl.Neuro, utilizes advanced machine learning techniques to automatically analyze MRI images, providing critical information on brain structures such as grey matter, white matter, and intracranial volumes. This technology enables the extraction of neuroimaging biomarkers, facilitating improved insights and decision-making in both clinical studies and routine practice. By seamlessly integrating into the workflows of imaging contract research organizations, neuroradiologists, and neurologists, Pixyl supports data-driven and value-based patient care, particularly for conditions such as multiple sclerosis, stroke, and neurodegenerative diseases.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

OncoDiag is a biotechnology company based in Normandy, France, specializing in the development of non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, Urotest, is a urine test designed for the diagnosis and monitoring of bladder cancer. Additionally, the company is advancing its pipeline with Colodiag, which focuses on the early detection of colorectal cancer. OncoDiag's portfolio also includes a tissue-based test for predicting non-evolutive localized prostate cancer. By offering these innovative diagnostic solutions, OncoDiag aims to enhance the capabilities of healthcare professionals in cancer diagnosis and management.

Omini is a biotechnology company based in Saint Mandé, France, founded in 2019. It specializes in the development of portable and multipurpose bio-sensing devices designed for immediate blood testing. Omini's biosensor platform enables the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to customize therapies and prevent acute crises in patients with chronic conditions. By leveraging multiplex electrochemical biosensor technology, the company offers affordable and accurate monitoring solutions that facilitate decentralized testing and at-home monitoring, ultimately helping to alleviate the burden on healthcare systems. Omini primarily serves general practitioners, aiming to enhance patient care through innovative diagnostic tools.

Grapheal is a Medtech startup focused on developing innovative embedded and wearable biosensors designed for modern healthcare applications. Leveraging advanced graphene transistors, Grapheal's devices enable accurate and affordable field diagnostics and remote patient monitoring. Their biosensors, which are minimalistic in design and integrated with wireless connectivity, allow for the precise detection of biomarkers and pathogens, all accessible through a smartphone. The company’s approach encompasses the entire value chain, from synthesizing proprietary sensing nanomaterials to the integration of sensor technology with embedded data analysis and software development, thus facilitating enhanced medical oversight for professionals.

Apneal is a healthcare technology company that specializes in sleep diagnostics. It has developed a mobile application designed to diagnose sleep apnea by utilizing a smartphone's built-in sensors, such as microphones, accelerometers, and gyroscopes, to monitor patients' sleep patterns. The app operates in airplane mode, ensuring it does not emit or receive electromagnetic waves during use. By employing deep learning algorithms, Apneal transforms smartphones into medical devices capable of automatically detecting cardio-respiratory events and analyzing sleep quality through interpretable signals. The results of these assessments are then presented to healthcare providers on an ergonomic dashboard, allowing for timely evaluations without the need for cumbersome equipment or extended waiting periods.

CorWave is a company focused on developing innovative implanted cardiac support devices aimed at improving the quality of life for patients suffering from heart failure. Its flagship product, the CorWave LVAD, employs a unique undulating disc wave pumping mechanism, which replaces traditional high-speed impellers used in current continuous flow rotary pumps. This design significantly reduces trauma to blood, thereby minimizing complications such as clotting and bleeding. The CorWave pump generates a pulsatile flow that closely resembles the natural heartbeat, addressing a key limitation of existing LVADs that provide only continuous flow. Additionally, the device's low power consumption and compact size facilitate its potential for complete implantation, enhanced by a wireless energy transfer system. Through these advancements, CorWave aims to alleviate the burdens associated with heart failure and invasive surgical procedures.

Lucine is a company focused on improving patient health, primarily targeting pain management. It develops a mobile health application that offers a digital therapeutic solution designed to relieve pain within five minutes through analgesic neurostimulation. The application employs advanced algorithms to measure and analyze pain by utilizing facial, vocal, and postural recognition. This technology allows for personalized treatment, as it instantly adapts to each patient's specific needs. The application provides a variety of techniques to alleviate pain symptoms, including exercises, relaxation methods, art therapy, and meditation, empowering patients with chronic pain to manage their conditions effectively from home.

Braintale is a Paris-based company founded in 2018 that specializes in developing and distributing innovative diagnostic and prognostic tools specifically for brain-injured patients. The company's digital medical care platform is designed for hospitals to effectively analyze MRI reports, providing accessible solutions that meet the needs of healthcare professionals and patients alike. Braintale’s products are grounded in over 15 years of clinical development, focusing on predicting patient outcomes, particularly for those in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. By facilitating easier diagnoses, Braintale aims to enhance patient care in critical settings, ultimately improving the prognosis for individuals with severe brain injuries.

Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that connects patients with healthcare professionals for immediate medical advice. The platform allows users to contact general practitioners, pediatricians, gynecologists, and psychologists at any time, facilitating access to necessary assistance for various medical issues and emergencies. By enabling direct communication between patients and doctors, Medaviz aims to streamline the process of obtaining medical guidance and support.

SideROS is a biotechnology company based in Paris, France, focused on developing innovative treatments for cancer. Founded in 2019, it specializes in research on iron-targeting chemical compounds aimed at attacking persister cancer cells, which are resistant to conventional therapies and often lead to metastasis and relapse. The company's primary candidate, ironomycin, disrupts iron homeostasis in these cells, inducing cell death through a process known as ferroptosis. By targeting the unique vulnerabilities of persister cancer cells, SideROS aims to provide new therapeutic options for patients facing challenging cancer cases.

Synapse Medicine is a company based in Bordeaux, France, that specializes in developing an online medical intelligence platform aimed at improving drug prescription management for healthcare professionals. Founded in 2017, the company has created a comprehensive knowledge base that utilizes algorithms to deliver reliable and up-to-date information about medications. This platform allows doctors and pharmacists to analyze treatment options in real time, ensuring the safety and efficacy of drug therapies. By working with leading hospitals and digital health companies across the United States, Europe, and Japan, Synapse Medicine is committed to transforming medication management and enhancing patient care through innovative technology solutions.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

Cardiologs is a medical technology company founded in 2014, focused on transforming cardiac diagnostics through the use of medical-grade artificial intelligence and cloud technology. The company's flagship product, the Cardiologs Holter solution, leverages a proprietary database of over 18 million cardiac recordings, which is continuously expanding and supported by numerous clinical publications that validate its diagnostic performance. Cardiologs aims to democratize expert cardiac care globally by providing healthcare practitioners and clinicians with advanced tools, including an automatic heart disorder screener and electrocardiogram analysis services powered by machine learning algorithms. This technology enhances physicians' capabilities in interpreting electrocardiograms, making expert cardiac diagnostics more scalable and accessible.

Deeplink Medical is a developer of a teleradiology platform designed to address the specific needs of healthcare professionals in telemedicine. Founded by an experienced medical team, the company creates innovative tools that enhance the management of patient care through telemedicine projects. Its platform streamlines the process of requesting imaging examinations and standardizes examination protocols, ensuring the efficient transmission of essential data among healthcare providers. By enabling users to operate independently in their teleradiology activities, Deeplink Medical supports the successful implementation of telemedicine solutions while offering comprehensive support, training, and monitoring practices to optimize patient management.

Neurallys is a Paris-based company that specializes in developing and producing medical devices focused on neurology and neurosurgery. The company has created an intelligent sensor that communicates with a smartphone to monitor intracranial pressure in patients suffering from hydrocephalus. This innovative device aims to enhance patient comfort and provides neurosurgeons with an effective tool for monitoring and managing the condition. By facilitating better follow-up care, Neurallys' technology seeks to improve the overall quality of treatment for individuals affected by this pathology.

Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.

Happytal, founded in 2013 and based in Vanves, France, specializes in enhancing the hospital experience through personalized concierge services. The company offers a range of amenities designed to improve patient comfort during hospital stays, including the provision of hairdressing and beautician services, delivery of newspapers, and access to local food products. Furthermore, Happytal enables patients to request additional services such as massages and childcare, ensuring that daily habits are maintained and patients feel supported throughout their hospitalization. By combining human and digital resources, Happytal aims to create a more pleasant and accommodating environment for patients and their families in healthcare facilities.

Foodvisor is a nutrition application that aids users in adopting healthier eating habits by providing detailed nutritional information. Utilizing the camera on a smartphone, the app recognizes food items on a user's plate and estimates their serving sizes. In just seconds, it generates a comprehensive nutrition report, offering insights that go beyond simple calorie counting. This functionality empowers users to make informed dietary choices and work towards a more balanced diet. Foodvisor's innovative approach positions it as a valuable tool for individuals seeking to improve their nutrition and overall health.

C4Diagnostics is a developer of in vitro diagnostic (IVD) kits that leverages proprietary technology to enhance the speed and sensitivity of diagnostic testing. The company focuses on creating medical devices and equipment that streamline the screening process for urinary tract infections, allowing for the reliable detection, counting, and concentration of relevant microorganisms in clinical microbiology. By enabling hospitals and laboratories to conduct culture-based IVD tests and specific fluorescence assessments, C4Diagnostics contributes to more efficient and effective diagnostic practices in healthcare settings.

Core for Tech is a deep technology company dedicated to enhancing road safety by measuring and predicting driver drowsiness through heart rate variability analysis. By utilizing native sensors or retrofit technology in vehicles, the company transforms physiological data into actionable insights regarding a driver's fatigue levels. This innovative approach allows for the early detection of drowsiness, enabling timely interventions to prevent accidents caused by sleepiness. With a mission centered on safety, Core for Tech aims to provide drivers with the information they need to make informed decisions about their alertness while driving.

Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Dreem is a neurotechnology company focused on enhancing human potential through innovative consumer technology. Its primary product is a wearable device that improves the quality of deep sleep by monitoring brainwaves and analyzing sleep patterns. The device employs sound stimulation to extend deep sleep duration, which can lead to improved daily performance. By utilizing machine learning algorithms, Dreem's headband provides real-time analysis of sleep stages and delivers personalized insights and tips that adapt based on individual sleeping habits. This approach aims to help users achieve faster sleep onset, longer deep sleep, and a refreshed awakening.

RUBIX S&I SAS is an analytical company based in Toulouse, France, specializing in electronic monitoring devices and software solutions for assessing air quality, noise, and odors. Founded in 2016 by Jean-Christophe Mifsud, the company offers a range of products, including the WatchTower series and Rubix Home, which provide real-time data analytics on environmental nuisances and indoor air quality. The WatchTower devices utilize various gas sensor arrays to monitor both indoor and outdoor air emissions. RUBIX S&I is committed to enhancing safety and wellness in work environments through its innovative Internet of Things (IoT) modules and online instruments, addressing both business-to-business and business-to-consumer markets.

Core for Tech is a deep technology company dedicated to enhancing road safety by measuring and predicting driver drowsiness through heart rate variability analysis. By utilizing native sensors or retrofit technology in vehicles, the company transforms physiological data into actionable insights regarding a driver's fatigue levels. This innovative approach allows for the early detection of drowsiness, enabling timely interventions to prevent accidents caused by sleepiness. With a mission centered on safety, Core for Tech aims to provide drivers with the information they need to make informed decisions about their alertness while driving.

Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.

Cardiologs is a medical technology company founded in 2014, focused on transforming cardiac diagnostics through the use of medical-grade artificial intelligence and cloud technology. The company's flagship product, the Cardiologs Holter solution, leverages a proprietary database of over 18 million cardiac recordings, which is continuously expanding and supported by numerous clinical publications that validate its diagnostic performance. Cardiologs aims to democratize expert cardiac care globally by providing healthcare practitioners and clinicians with advanced tools, including an automatic heart disorder screener and electrocardiogram analysis services powered by machine learning algorithms. This technology enhances physicians' capabilities in interpreting electrocardiograms, making expert cardiac diagnostics more scalable and accessible.

OpenHealth Company specializes in the real-time processing and analysis of health consumption data. The company's innovative platform collects health data from various sources, including pharmacies, outpatient medical facilities, and patient longitudinal records. By transforming this data into actionable insights, OpenHealth aims to enhance healthcare decision-making. Its services cater to a diverse clientele, including health authorities, industry stakeholders, researchers, and the general public, providing valuable information for both marketing and clinical research purposes.

Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.

Nomadeec is a mobile telemedicine platform developed by Exelus SAS, specializing in emergency and scheduled care. As a leader in remote medical control in France, Nomadeec offers a powerful and intuitive tool that enhances decision-making in urgent situations, thereby improving patient outcomes. The platform is versatile and tailored to the needs of various healthcare professionals, including emergency doctors, sports physicians, and paramedics. It facilitates real-time communication between healthcare providers and patients, enabling teleconsultations, tele-expertise, and tele-triage. By optimizing the quality of prehospital care, Nomadeec effectively addresses healthcare access issues in underserved areas and helps prevent unnecessary hospitalizations, allowing healthcare professionals to deliver timely assistance in both emergency and routine medical contexts.

UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

CorWave is a company focused on developing innovative implanted cardiac support devices aimed at improving the quality of life for patients suffering from heart failure. Its flagship product, the CorWave LVAD, employs a unique undulating disc wave pumping mechanism, which replaces traditional high-speed impellers used in current continuous flow rotary pumps. This design significantly reduces trauma to blood, thereby minimizing complications such as clotting and bleeding. The CorWave pump generates a pulsatile flow that closely resembles the natural heartbeat, addressing a key limitation of existing LVADs that provide only continuous flow. Additionally, the device's low power consumption and compact size facilitate its potential for complete implantation, enhanced by a wireless energy transfer system. Through these advancements, CorWave aims to alleviate the burdens associated with heart failure and invasive surgical procedures.

Omind Neurotechnologies specializes in developing neurotraining services and content grounded in applied neurosciences and neurotechnology. The company offers a scientific and experiential coaching platform that utilizes multimodal techniques to evaluate and personalize training strategies. Its resources include a normative database, VR stimuli, and real-time multimodal signal processing through its TimeFlux technology. Additionally, Omind maintains an anonymized repository, Quetzal, and holds various intellectual properties and trade secrets related to neurotechnology. By focusing on enhancing collective intelligence, group resilience, and team dynamics, the company aims to help clients effectively manage their emotions and improve decision-making and efficiency in daily life.

SpineGuard is a French medical company focused on the design and production of innovative instruments for spinal surgeries, utilizing its proprietary Dynamic Surgical Guidance (DSG®) technology. This powerful, radiation-free sensing platform enhances the accuracy and safety of skeletal implant placement through real-time audio and visual feedback for surgeons. The company's flagship product, the PediGuard probe, is specifically designed for spine surgery, allowing surgeons to create pilot holes in vertebrae with precision. Equipped with a sensor that measures electrical conductivity, the PediGuard alerts surgeons to changes in bone and tissue types without the need for X-ray imaging. Available in various shapes and sizes, these devices cater to a wide range of surgical needs, from pediatric deformity corrections to adult degenerative conditions. With over 80,000 successful spinal procedures supported by PediGuard and substantial clinical evidence backing its efficacy, SpineGuard aims to address critical challenges in pedicle screw placement while improving patient outcomes and operational efficiency in the surgical environment.

Cardiologs is a medical technology company founded in 2014, focused on transforming cardiac diagnostics through the use of medical-grade artificial intelligence and cloud technology. The company's flagship product, the Cardiologs Holter solution, leverages a proprietary database of over 18 million cardiac recordings, which is continuously expanding and supported by numerous clinical publications that validate its diagnostic performance. Cardiologs aims to democratize expert cardiac care globally by providing healthcare practitioners and clinicians with advanced tools, including an automatic heart disorder screener and electrocardiogram analysis services powered by machine learning algorithms. This technology enhances physicians' capabilities in interpreting electrocardiograms, making expert cardiac diagnostics more scalable and accessible.

Biom'Up S.A. is a French company specializing in the development and commercialization of innovative hemostatic products and absorbable medical devices based on patented biopolymer and collagen technologies. Founded in 2005 and headquartered in Saint-Priest, France, Biom'Up designs and manufactures medical devices aimed at improving surgical outcomes across various specialties, including orthopedic, spinal, cardiac, general, and maxillofacial surgeries. Its flagship products, such as HEMOBLAST bellows and associated laparoscopic applicators, are clinically proven to enhance patient healing by facilitating guided regeneration of soft tissues and bone. The company markets its products primarily in Europe and the United States, contributing significantly to the field of biosurgery.

Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires

Theravectys is a development-stage biotechnology company focused on creating innovative vaccine solutions for the treatment and prevention of infectious diseases, cancers, and various medical conditions. The company has developed a unique therapeutic vaccination technology that utilizes gene transfer into dendritic cells to modulate the immune response. This approach aims to provide both prophylactic and therapeutic immunotherapies, enhancing the ability of healthcare providers to address critical health needs. Theravectys' lead product, a therapeutic vaccine for HIV/AIDS, has demonstrated promising efficacy and safety in non-human primate studies and is set to enter its first clinical trials, reflecting the company's commitment to advancing its diverse pipeline of treatments.

Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.

Voluntis, established in 2001, specializes in developing digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. The company offers products such as Insulia, Diabeo, Oleena, and AstraZeneca, which provide automated insulin dose recommendations, patient-specific dosage suggestions, and management of side effects like hypertension and diarrhea. Voluntis collaborates with pharmaceutical companies like Bristol-Myers Squibb to co-develop digital therapeutics for oncology. With a patient-centric approach, Voluntis aims to enhance medical practices and improve healthcare system efficiency through secure, collaborative, and innovative digital health solutions.

Skuldtech is specialized in the discovery of new Biomarkers and the development of Diagnostics focused on personalized medicine applications. This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics associated with new treatments, especially in cancer, neurodegenerative and infectious diseases.

Nanobiotix SA is a clinical-stage biotechnology company based in Paris, France, focused on advancing cancer treatment through its innovative nanomedicine programs. The company is known for its proprietary NanoXray technology, which enhances the effectiveness of radiotherapy by amplifying its impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its key products, NBTXR3, is a radio-enhancer composed of hafnium oxide designed for treating various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. Founded in 2003, Nanobiotix is dedicated to transforming cancer therapy and improving patient outcomes using its advanced nanotechnology solutions.

Nanobiotix SA is a clinical-stage biotechnology company based in Paris, France, focused on advancing cancer treatment through its innovative nanomedicine programs. The company is known for its proprietary NanoXray technology, which enhances the effectiveness of radiotherapy by amplifying its impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its key products, NBTXR3, is a radio-enhancer composed of hafnium oxide designed for treating various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. Founded in 2003, Nanobiotix is dedicated to transforming cancer therapy and improving patient outcomes using its advanced nanotechnology solutions.